巨噬细胞诱导的羧肽酶A4促进未分化甲状腺癌进展
本研究探讨巨噬细胞与未分化甲状腺癌细胞间的相互作用,通过共培养和蛋白质组学分析发现M2巨噬细胞分泌的羧肽酶A4(CPA4)介导两者对话,CPA4在未分化甲状腺癌中高表达且与不良预后相关,敲低CPA4可抑制肿瘤细胞增殖、迁移和侵袭。
要点
- M2巨噬细胞增加未分化甲状腺癌细胞的增殖、迁移和侵袭,M1巨噬细胞则降低这些表型。
- CPA4仅在M2巨噬细胞与8505C共培养培养基中检出,M2巨噬细胞可上调癌细胞CPA4表达。
- 敲低CPA4抑制未分化甲状腺癌细胞增殖、集落形成、迁移和侵袭,并减少STAT3、ERK、AKT/mTOR磷酸化及EMT标志物表达。
核心结论
- 数据提示CPA4通过介导M2巨噬细胞与未分化甲状腺癌细胞之间的相互作用刺激甲状腺癌进展。
- CPA4可能成为治疗未分化甲状腺癌患者的新治疗靶点。
研究设计与样本
- 研究采用共培养实验和条件培养基评估巨噬细胞对未分化甲状腺癌细胞增殖、迁移和侵袭的作用。
- 采用液相色谱-串联质谱蛋白质组学分析单一培养或共培养条件培养基中的分泌因子。
- 使用体内异种移植模型评估该因子的效应。
主要发现
- M2巨噬细胞显著增加未分化甲状腺癌细胞的增殖、迁移和侵袭,而M1巨噬细胞降低未分化甲状腺癌细胞的增殖、迁移和侵袭。
- CPA4仅在M2巨噬细胞/8505C共培养培养基中检出,M2巨噬细胞使癌细胞中CPA4表达增加。
- CPA4蛋白在人甲状腺癌尤其未分化甲状腺癌中的表达显著高于正常和良性组织。
- 公共数据生物信息学分析显示CPA4表达与甲状腺癌不良预后和去分化相关。
- 敲低CPA4抑制未分化甲状腺癌细胞的增殖、集落形成、迁移和侵袭,与STAT3、ERK和AKT/mTOR磷酸化及上皮-间质转化标志物表达下降一致。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The density of tumor-associated macrophages in the tumor microenvironment of anaplastic thyroid cancer (ATC) is associated with poor prognosis. However, the crosstalk between macrophages and ATC cells is poorly understood. This study aimed to examine the impact of macrophages on cancer cell phenotypes. We found a new mediator between M2 macrophages and ATC cells through proteomics analysis. Methods: The role of macrophages in proliferation, migration, and invasion of ATC cells was evaluated using coculture assay and conditioned medium (CM). Secretory factors in the CM from single or coculture were identified using liquid chromatography-tandem mass spectrometry proteomics analysis. We evaluated the role of the secretory factor in proliferation, migration, and invasion of cancer cells. In vivo xenograft model was used to evaluate the effect of the factor. Results: M2 macrophages significantly increased the proliferation, migration, and invasion of ATC cells, whereas M1 macrophages decreased the proliferation, migration, and invasion of ATC cells. Based on proteomic analysis of CM, we identify carboxypeptidase A4 (CPA4) as a mediator of the crosstalk between macrophages and ATC cells. CPA4 was only detected in the coculture media of M2 macrophage/8505C, and its expression in cancer cells increased by M2 macrophage. The expression of CPA4 protein was significantly higher in human thyroid cancers, particularly in ATCs, than normal and benign tissues. A bioinformatics analysis of public data revealed that CPA4 expression was associated with poor prognosis and dedifferentiation of thyroid cancer. Knockdown of CPA4 suppressed proliferation, colony formation, migration, and invasion of ATC cells, consistent with the decrease of STAT3, ERK, and AKT/mTOR phosphorylation and epithelial-mesenchymal transition (EMT) marker expression. In addition, the increased expression of CPA4 in cancer cells by M2 macrophage stimulation induced the polarization of macrophages to the M2 phenotype, which formed a positive feedback loop. Xenograft tumors did not develop after CPA4 knockdown. Conclusions: Our data suggest that CPA4 stimulates the progression of thyroid cancer by mediating between M2 macrophages and ATC cells. CPA4 can be a new therapeutic target for the treatment of patients with ATC.
引用
- Choi YS, Jeon MJ, Doolittle WKL, et al. Macrophage-Induced Carboxypeptidase A4 Promotes the Progression of Anaplastic Thyroid Cancer. Thyroid. 2024. PMID: 38666696. doi:10.1089/thy.2023.0427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。